Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

226
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
226
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

682
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
682
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

221
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
221

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary Protein Reduction During Isocaloric Conditions Reduces Body Weight in Men With Overweight or Obesity.

Obesity (Silver Spring, Md.)·2026
Same author

High-Dose Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury: The VICTORY Randomized Clinical Trial.

JAMA·2026
Same author

Employment Status and Later Life Cognitive Functioning: A Gendered Perspective on the Moderating Role of the Social Network.

Research on aging·2026
Same author

Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.

Blood immunology & cellular therapy·2026
Same author

Mapping inequalities in the health of older adults around the world: Heterogeneities in cognitive and physical functioning.

Vienna yearbook of population research·2026
Same author

Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Enhancing Volumetric Imaging in Linear-Array Photoacoustic Tomography: multiview fusion with deep learning.

IEEE transactions on bio-medical engineering·2026
Same journal

Robust Rule-based Heuristic Assistance Strategy for a Semi-Active Shoulder Exoskeleton Used in Overhead Work.

IEEE transactions on bio-medical engineering·2026
Same journal

Highly Accelerated 1-mm Isotropic 3D Chemical Exchange Saturation Transfer MRI Using Wave-Co-CAIPI at 5 Tesla.

IEEE transactions on bio-medical engineering·2026
Same journal

Systematic Evaluation of Hip Exoskeleton Assistance Parameters for Enhancing Gait Stability During Ground Slip Perturbations.

IEEE transactions on bio-medical engineering·2026
Same journal

SleepConFormer: A Single-Channel EEG Framework for Sleep Staging and Consciousness Assessment in Patients with Disorders of Consciousness.

IEEE transactions on bio-medical engineering·2026
Same journal

Modeling Partial and Total Support of Left Ventricular Assist Device for Discrete Hemodynamic Control Framework.

IEEE transactions on bio-medical engineering·2026
See all related articles

Related Experiment Video

Updated: Dec 21, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Model-Based Optimal AML Consolidation Treatment.

Felix Jost, Enrico Schalk, Daniela Weber

    IEEE Transactions on Bio-Medical Engineering
    |May 15, 2020
    PubMed
    Summary
    This summary is machine-generated.

    This study developed a mathematical model to optimize chemotherapy for acute myeloid leukemia (AML), improving white blood cell (WBC) counts and reducing treatment intensity for better patient outcomes.

    More Related Videos

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
    08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    462
    A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
    08:05

    A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

    Published on: January 5, 2018

    10.1K

    Related Experiment Videos

    Last Updated: Dec 21, 2025

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.6K
    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
    08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    462
    A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
    08:05

    A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

    Published on: January 5, 2018

    10.1K

    Area of Science:

    • Pharmacometrics
    • Mathematical Modeling
    • Oncology

    Background:

    • Neutropenia is a common chemotherapy side effect in acute myeloid leukemia (AML), increasing infection risk.
    • Current AML treatment lacks validated models to simultaneously track white blood cell (WBC) counts and leukemic cells.
    • Optimizing chemotherapy could reduce side effects and improve remission rates.

    Purpose of the Study:

    • To develop and validate a mathematical model for simulating chemotherapy effects in AML.
    • To optimize treatment schedules for AML patients, balancing disease control and neutropenia.
    • To evaluate the impact of optimized schedules on WBC nadirs and drug dosage.

    Main Methods:

    • Developed a population pharmacokinetic/pharmacodynamic (PK/PD) model integrating myelosuppression, G-CSF, cytarabine (Ara-C), and leukemic blasts.
    • Fitted the model to data from 44 AML patients in a phase II clinical trial.
    • Utilized the model for in silico optimization of Ara-C and G-CSF treatment schedules.

    Main Results:

    • The PK/PD model accurately predicted interactions between WBCs, G-CSF, and blasts.
    • Simulations showed a median 4.2-fold increase in WBC count at nadir for 14 patients.
    • Optimized schedules maintained blast counts below 5% with a median 60% Ara-C reduction.

    Conclusions:

    • The developed PK/PD model effectively simulates AML chemotherapy.
    • In silico optimization demonstrates potential benefits for AML patient treatment.
    • Optimized schedules may lead to improved WBC recovery and reduced drug exposure.